Drug Profile
UK 57562
Alternative Names: UK 5756201Latest Information Update: 09 Oct 2006
Price :
$50
*
At a glance
- Originator Pfizer
- Class Antibacterials; Small molecules; Tetracyclines
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 09 Oct 2006 Discontinued - Preclinical for Bacterial infections in USA (unspecified route)
- 23 Jun 2000 Pfizer has merged with Warner-Lambert
- 20 Oct 1999 New profile